<DOC>
	<DOCNO>NCT00740012</DOCNO>
	<brief_summary>Study hypothesis : Waking response alarm clock may evoke stress reaction lead rise glucose concentration . The purpose study prove hypothesis continuous glucose monitoring three night . Night ( ) alarm clock set 2 h interval glucose self monitoring , Night ( b ) nurse perform blood glucose determination , Night ( c ) patient leave undisturbed .</brief_summary>
	<brief_title>Glycemic Rises After Waking Up In Response To An Alarm Clock In Type 1-Diabetic Patients Analysed With Continuous Glucose Monitoring ( GlucoDay® )</brief_title>
	<detailed_description>To provide nocturnal glucose control patient type 1 diabetes therapeutic challenge . Nocturnal glucose profile important tool secure adequate glycemic control night . Often , patient ask perform self-monitoring help alarm clock . Such recommendation depend accuracy glucose concentration determine way . We hypothesize alarm clock may trigger stressful arousal might accompany rise glucose concentration , consecutively lead nocturnal glucose profile representative undisturbed condition . We want prove hypothesis 30 patient three night . Night ( ) alarm clock set 2 h interval ( midnight , 2 a.m. , 4a.m . 6:45 a.m ) glucose self monitoring , Night ( b ) nurse perform blood glucose determination 2 h interval ( midnight , 2 a.m. , 4a.m . 6:45 a.m ) , Night ( c ) patient leave undisturbed . All patient go use continuous glucose monitor half patient ( uneven number ) go indwell venous cannula night ( ) ( b . During night ( ) ( b ) 5-7 minute schedule time glucose measurement doctoral candidate go take pulse , another capillary blood sample laboratory glucose determination ( EBIOS , Eppendorf , Hamburg , Germany ) . Also doctoral candidate go take venous blood sample half patient ( uneven number ) , blood indwell venous cannula determination epinephrine , norepinephrine , cortisol , glucagon , growth hormone , prolactin ( determine specific immunoassay Biocientia laboratory , Jena , Germany ) .</detailed_description>
	<criteria>Type 1 Diabetic patient ( diagnose longer 2 year ) HBA1c 5,0 9,5 % Age 1875 year Hospitalized patient Male female , female exclusion pregnancy secure contraception BodyMassIndex 1940 kg/m² Patient elucidate Patients agreement Type 2Diabetic patient forms diabetes beside type 1 diabetes , diagnose guideline Deutsche Diabetes Gesellschaft HbA1c &lt; 5,0 % &gt; 9,5 % A severe hypoglycemia unconsciousness within last 2 month BodyMassIndex &lt; 19 &gt; 40 kg/m² No patient agreement Pregnancy ( positive pregnancy test ) unsecured contraception . Agina pectoris acute myocardial infarct , continuous problem Inadequate treat arterial hypertension &gt; 160 mmHg systolic and/or &lt; 95 mmHg diastolic Active tumor disease Anemia hemoglobin &lt; 11,5 g/dl Treatment steroid , sedative anesthetic Infection/fewer &gt; 37.5 °C Renal malfunction ( serum creatinine &gt; 1.5 mg/dl ) Liver malfunction ( GPT AP &gt; double upper limit ) Alcohol drug abuse Sleep disorder Participation clinical study within last 3 month Other significant health dysfunction , would affect outcome study Incapable conform requirement protocol</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>September 2008</verification_date>
	<keyword>Nocturnal glucose profile</keyword>
	<keyword>continuous glucose profile</keyword>
</DOC>